NASDAQ: ESPR       Esperion Theraptc Cmn
Last Price Today's Change   Day's Range   Trading Volume
32.99   -0.32 (0.96%)  32.63 - 34.47  226,489


Avg Volume (4 weeks):647,742
4 Weeks Range:32.63 - 38.52
4 Weeks Price Volatility (%):
52 Weeks Range:9.40 - 48.21
52 Weeks Price Volatility (%):
Average Price Target: 93.00
Price Target Upside/Downside: +60.01


No recent Headlines for this stock.

Business Background

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the Company's lead product candidate, is an orally available, once-daily adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor that reduces cholesterol biosynthesis and lowers elevated levels of LDL-C by up-regulating the LDL receptor, but with reduced potential for muscle-related side effects. In addition to bempedoic acid as monotherapy, the Company is also developing bempedoic acid in a fixed dose combination with ezetimibe, an approved, non-statin, oral, LDL-C lowering therapy. As of December 31, 2016, the Company was engaged in conducting its global Phase III clinical development program for bempedoic acid.

  Be the first to like this.


3262  3271  752  1078 

Top 10 Active Counters
 NTRSP 27.04-0.04 
 F 11.04+0.17 
 AMD 11.08-0.33 
 BAC 22.855-0.195 
 DCTH 0.030.00 
 XLF 23.295-0.055 
 TVIX 26.18-1.99 
 PBR 8.66-0.30 
 HUN 26.52-0.19 
 VXX 14.12-0.52 
Partners & Brokers